(Q82603453)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22102173%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

title

A C118T polymorphism of ERCC1 and response to cisplatin chemotherapy in patients with late-stage non-small cell lung cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22102173%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference

Jian Cheng

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22102173%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Minwen Ha

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22102173%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Yadi Wang

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22102173%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Jing Sun

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22102173%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Junchen Chen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22102173%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Yue Wang

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22102173%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Chunyan Tong

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22102173%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

publication date

20 November 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22102173%20AND%20SRC:MED&resulttype=core&format=json

Journal of Cancer Research and Clinical Oncology

17 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22102173%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

volume

138

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22102173%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22102173%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

page(s)

231-238

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22102173%20AND%20SRC:MED&resulttype=core&format=json

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

17 January 2020

cites work

1 reference

12 December 2020

Effects of excision repair cross-complementation group 1 (ERCC1) single nucleotide polymorphisms on the prognosis of non-small cell lung cancer patients

1 reference

12 December 2020

ERCC1 gene polymorphism as a predictor for clinical outcome in advanced colorectal cancer patients treated with platinum-based chemotherapy.

1 reference

12 December 2020

DNA repair and cisplatin resistance in non-small-cell lung cancer

1 reference

12 December 2020

Single nucleotide polymorphisms and outcome in docetaxel-cisplatin-treated advanced non-small-cell lung cancer

1 reference

12 December 2020

Small cell lung cancer: defining a role for emerging platinum drugs

1 reference

12 December 2020

Prognostic value of expression of ERCC1, thymidylate synthase, and glutathione S-transferase P1 for 5-fluorouracil/oxaliplatin chemotherapy in advanced gastric cancer.

1 reference

12 December 2020

DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy

1 reference

12 December 2020

The Fanconi anemia pathway promotes replication-dependent DNA interstrand cross-link repair

1 reference

12 December 2020

Global cancer statistics, 2002

1 reference

12 December 2020

First-line systemic chemotherapy in the treatment of advanced non-small cell lung cancer: a systematic review

1 reference

12 December 2020

Prediction of response to chemotherapy by ERCC1 immunohistochemistry and ERCC1 polymorphism in ovarian cancer

1 reference

12 December 2020

Gene expression and polymorphisms of DNA repair enzymes: cancer susceptibility and response to chemotherapy.

1 reference

12 December 2020

ERCC1 codon 118 polymorphism is a predictive factor for the tumor response to oxaliplatin/5-fluorouracil combination chemotherapy in patients with advanced colorectal cancer.

1 reference

12 December 2020

No association of ERCC1 C8092A and T19007C polymorphisms to cancer risk: a meta-analysis.

1 reference

12 December 2020

Randomized phase III study of cisplatin plus irinotecan versus carboplatin plus paclitaxel, cisplatin plus gemcitabine, and cisplatin plus vinorelbine for advanced non-small-cell lung cancer: Four-Arm Cooperative Study in Japan.

1 reference

12 December 2020

Multiple roles of the ERCC1-XPF endonuclease in DNA repair and resistance to anticancer drugs

1 reference

12 December 2020

Oxaliplatin doublets in non-small cell lung cancer: a literature review

1 reference

12 December 2020

Genetic variation in the DNA repair genes is predictive of outcome in lung cancer

1 reference

12 December 2020

Mechanism of cis-diamminedichloroplatinum(II)-induced cytotoxicity: role of G2 arrest and DNA double-strand breaks

1 reference

12 December 2020

Correlation of CDA, ERCC1, and XPD polymorphisms with response and survival in gemcitabine/cisplatin-treated advanced non-small cell lung cancer patients.

1 reference

12 December 2020

XPD and XRCC1 genetic polymorphisms are prognostic factors in advanced non-small-cell lung cancer patients treated with platinum chemotherapy

1 reference

12 December 2020

Cancer burden in the year 2000. The global picture

1 reference

12 December 2020

Genetic polymorphisms and treatment response in advanced non-small cell lung cancer.

1 reference

12 December 2020

mRNA expression of RRM1, ERCC1 and ERCC2 is not associated with chemosensitivity to cisplatin, carboplatin and gemcitabine in human lung cancer cell lines

1 reference

12 December 2020

10.1007/S00432-011-1090-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22102173%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference